Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria

Patience Olayinka Akinwusi, Akinwumi Oluwole Komolafe, Olanrewaju Olayinka Olayemi, Adeleye Abiodun Adeomi, Patience Olayinka Akinwusi, Akinwumi Oluwole Komolafe, Olanrewaju Olayinka Olayemi, Adeleye Abiodun Adeomi

Abstract

Background: The purpose of this study was to determine the etiology and epidemiologic characteristics of sudden death at Ladoke Akintola University of Technology (LAUTECH) Teaching Hospital, South West Nigeria.

Methods: This was a retrospective descriptive study of all cases of natural unexpected death, either occurring out of hospital or less than 24 hours after admission to LAUTECH Teaching Hospital, over a nine-year period from January 2003 to December 2011. Data were generated from information in the case notes and autopsy reports for these cases.

Results: Sudden death accounted for 29 (4.0%) of 718 adult medical deaths and 1.0% of all adult medical admissions. Out-of-hospital deaths occurred in 72.4% of cases. The mean age of the patients was 46.8 ± 11.5 (range 25-74) years. The male to female ratio was 6.25:1. Cardiovascular disease were the most common cause of death (51.7%), followed by respiratory disease (20.7%), pulmonary thromboembolism (10.4%), central nervous system disease (13.8%), gastrointestinal disorders (13.8%), severe chemical/drug poisoning (13.8%), and combined cardiovascular and central nervous system disease (13.8%). Hypertension-related causes were responsible for 14/29 (48.3%) of the sudden deaths. Hypertensive heart disease accounted for 86.7% of the cardiovascular deaths, hypertensive heart failure accounted for 73.3%, whilst all heart failure cases accounted for 80.0%. Left ventricular hypertrophy was present in 69.2% of the patients with hypertensive heart disease. Moderate to severe atheromatous changes occurred in the aorta in 38.5% of patients aged ≥50 years. No case of myocardial infarction was found.

Conclusion: Hypertensive heart disease and hypertension-related disorders are the most common causes of sudden death in South West Nigeria, so effective public health strategies should be channeled towards prevention, detection, and treatment of hypertension.

Keywords: atheromatous changes; hypertensive heart disease; hypertensive heart failure; left ventricular hypertrophy; sudden cardiac death.

References

    1. World Health Organization . International Classification of Diseases. Geneva, Switzerland: World Health Organization; 2005.
    1. World Health Organization Technical Report Series. No 143. Classification of atherosclerotic lesions. Report of a study group Available from: Accessed May 8, 2013
    1. Engel GL. Psychological stress, vasodepressor (vasovagal) syncope, and sudden death. Ann Intern Med. 1978;89:403–412.
    1. Engel GL. Sudden and rapid death during psychological stress. Folklore or folk wisdom? Ann Intern Med. 1971;74:771–782.
    1. De Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, et al. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol. 1997;30:1500–1505.
    1. Zipes DP, Wellen HJ. Sudden cardiac death. Circulation. 1998;98:2334–2351.
    1. Zheng ZJ, Croft JR, Giles WH, Menash GA. Sudden cardiac death in the United States, 1989 to 1998. Am J Prev Med. 2005;29:36–41.
    1. Nofal HK, Abdulmohsen MF. Influence of age, gender and prodromal symptoms on sudden death in a tertiary care hospital, Eastern Saudi Arabia. J Family Community Med. 2010;17:83–86.
    1. Akinkugbe OO, Nicholson GD, Crickshank JK. Heart disease in blacks of Africa and the Caribbean. Cardiovasc Clin. 1991;21:377–391.
    1. Rotimi O, Ajayi AA, Odesanmi WO. Sudden unexpected death from cardiac causes in Nigerians: a review of 50 autopsied cases. Int J Cardiol. 1998;63:111–115.
    1. Rotimi O, Fatusi AO, Odesanmi WO. Sudden cardiac death in Nigerians – the Ile-Ife experience. West Afr J Med. 2004;23:27–31.
    1. Mandong BM, Manasseh AN, Ugwu BT. Medico-legal autopsies in North Central Nigeria. East Afr Med J. 2006;83:626–630.
    1. Tiemensma M, Burger EH. Sudden and unexplained deaths in an adult population, Cape Town, South Africa, 2001–2005. S Afr Med J. 2012;102:90–94.
    1. Ogah OS, Okpechi I, Chukwuonye II, et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: a review. World J Cardiol. 2012;4:327–340.
    1. Akinkugbe OO. Noncommunicable Diseases in Nigeria: Final Report of National Survey. Lagos, Nigeria: Federal Ministry of Health and Social Services; 1997.
    1. Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract. 2003;62:177–185.
    1. Nwafor A, Owhoji A. Prevalence of Diabetes Mellitus among Nigerians in Port Harcourt correlates with socio-economic status. J Appl Sci Environ Mgt. 2001;5:75–77.
    1. Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A prevalence of cardiometabolic risk factors among a rural Yoruba South-Western Nigeria population: a population-based survey. Cardiovasc J Afr. 2010;21:26–31.
    1. Akinkugbe OO. World epidemiology of hypertension in blacks. J Clin Hypertens. 1987;3(3 Suppl 1):1S–8S.
    1. Osuntokun BO. Stroke in Africans. Afr J Med Med Sci. 1977;6:39–53.
    1. Drazner MH. Contemporary reviews in cardiovascular medicine. The progression of hypertensive heart disease. Circulation. 2011;123:327–334.
    1. Zehender M, Faber T, Koscheck U, Meinertz T, Just H. Ventricular tachyarrhythmias, myocardial ischemia and sudden cardiac death in patients with hypertensive heart disease. Clin Cardiol. 1995;18:337–383.
    1. Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:495349.
    1. Ekore RI, Ajayi IO, Arije A. Case finding in young adult patients attending a missionary hospital in Nigeria. Afr Health Sci. 2009;9:193–199.
    1. Ayodele OE, Alebiosu CO, Akinwusi PO, Akinsola A, Mejiuni A. Target organ and associated clinical conditions in newly diagnosed hypertensives attending a tertiary health facility. Niger J Clin Pract. 2007;10:319–325.
    1. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374–1450.
    1. Siegel D, Cheitlin MD, Black DM, Seeley D, Hearst N, Hulley SB. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol. 1990;65:742–747.
    1. Spacek R, Gregor P. Ventricular arrhythmia of myocardial hypertrophy of various origins. Can J Cardiol. 1997;13:455–458.
    1. Novo S, Barbagallo M, Abrignani MG, et al. Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ischemia in hypertensives with left ventricular hypertrophy but without clinical history of coronary heart disease. Am J Hypertens. 1997;10:843–851.
    1. Anderson KP. Sudden death, hypertension and hypertrophy. J Cardiovasc Pharmacol. 1984;6( Suppl 3):S498.
    1. Burke AP, Farb A, Liang YH, Smialek J, Virmani R. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death. Circulation. 1996;94:3134–3145.
    1. Amakiri CN, Akang EE, Aghadiuno PU, Odesanmi WO. A prospective study of coroner’s autopsies in University College Hospital, Ibadan, Nigeria. Med Sci Law. 1997;37:69–75.
    1. Odesanmi WO. Forensic pathology in Nigeria: the Ife experience. Med Sci Law. 1982;22:269–272.
    1. Schatzkin A, Cupples LA, Heeren, et al. The epidemiology of sudden unexpected natural death. Risk factors for men and women in the Framingham Heart Study. Am Heart J. 1984;107:1300–1310.
    1. Schatzkin A, Cupples LA, Heeren, et al. Sudden death in the Framingham Heart Study: Differences in incidence and risk factors by sex and coronary disease status. Am J Epidemiol. 1984;120:888–895.
    1. Ajayi AA, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995;91:2742–2747.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe